Answer
Rifampicin is contraindicated with Vocabria (cabotegravir) injections because it significantly decreases cabotegravir plasma concentrations, likely causing loss of therapeutic effect, and dosing recommendations for co-administration have not been established.
Sources for this answer
- Vocabria 600 mg prolonged-release suspension for injectionViiV Healthcare UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 10Document updated
Sources checked